New cancer clinical trial: Study to Evaluate SHR6390 Combined With Pyrotinib in Patients With HER2 Positive Gastric Cancer

Published on: March 29, 2018 at 12:00PM
Condition:   Gastric Cancer
Intervention:   Drug: SHR6390
Sponsors:   Peking University;   Jiangsu HengRui Medicine Co., Ltd.
Not yet recruiting
https://ift.tt/2IgR2Jq